Product photograph of the current pack. Each physical unit carries the same blue-teal ZX label artwork, a batch code and a scratch-off verification panel.
Selective Estrogen Receptor Modulators
Aromasin
Exemestane
- Compound
- Exemestane
- Brand
- Aromasin
- Manufacturer
- Zyvex Pharmaceuticals
- Presentation
- 100 tabs
- Strength
- 20 mg/tab
- Route
- Oral
- Storage
- 15–25 °C, protected from light, do not freeze
Batch analysis
Independent batch results for Aromasin are not yet published. They will be added here once testing is complete.
Product information
About Aromasin
20 mg per tablet · 100 tablets · Zyvex Pharmaceuticals
Aromasin from Zyvex Pharmaceuticals contains exemestane at 20 mg per tablet and comes in a pack of 100 tablets.
This prospect summarises composition, clinical considerations and handling. It supports professional review and does not replace an individual prescription or verified instructions for the exact preparation.
Basic Identification & Composition
Product Name & Active Ingredient
Aromasin is the product name used by Zyvex Pharmaceuticals. The ingredient discussed in the following sections is exemestane, classified as a steroidal aromatase inhibitor.
Qualitative & Quantitative Composition
| Property | Details |
|---|---|
| Product name | Aromasin |
| Manufacturer | Zyvex Pharmaceuticals |
| Active ingredient | Exemestane |
| Strength | 20 mg per tablet |
| Package | 100 tablets |
| Drug class | Steroidal aromatase inhibitor |
| Chemical formula | C20H24O2 |
| Dosage form and route | Tablet; oral |
Dosage Form
A solid tablet for oral administration. Each tablet provides a measured amount of active ingredient. Confirm suitability with a pharmacist before splitting or crushing; appearance and score lines alone do not establish accurate dose division.
Clinical Particulars
Aromasin uses
Aromasin from Zyvex Pharmaceuticals contains exemestane. Exemestane is used in hormone-sensitive breast cancer after menopause, including treatment following tamoxifen. The medical reference dose is 25 mg orally once daily after food. The 20 mg tablet in this product does not reproduce that dose.
In performance-enhancement settings, people use exemestane to lower oestrogen during or after anabolic-steroid use. Their aim is often to reduce breast symptoms or other effects attributed to aromatisation; lowering oestrogen can also cause joint symptoms and bone loss.
An analysis of online steroid discussions reported a mean dose of 10 mg daily and median duration of 84 days. These observational figures are not a tested treatment schedule and do not establish accurate division of a 20 mg tablet.
Dosage and Administration
Reference prescribing information describes exemestane 25 mg once daily after a meal. Aromasin from Zyvex Pharmaceuticals contains 20 mg per tablet, so a one-tablet substitution would not reproduce that reference dose. A prescriber and pharmacist must resolve the appropriate formulation and dose. Do not improvise tablet fractions or increase the tablet count.
Contraindications
Do not use with hypersensitivity to exemestane or any tablet ingredient. Treatment is not appropriate during pregnancy.
Warnings and Precautions
Oestrogen suppression can reduce bone density. Review fracture risk, vitamin D status and bone health before and during treatment. Liver or kidney disease can alter exposure and should be discussed with the prescriber.
Risks and Interactions
Drug & Food Interactions
Strong CYP3A4 inducers, including rifampicin, some antiseizure medicines and St John's wort, can reduce exposure. Oestrogen-containing products may oppose the intended pharmacological action. Any dose adjustment belongs to the prescriber.
Pregnancy and Lactation
Exemestane can harm a developing fetus. Avoid pregnancy and breastfeeding during treatment and confirm contraception and post-treatment precautions with the clinician.
Side Effects and Adverse Reactions
Reported reactions include hot flushes, fatigue, joint pain, headache, insomnia and nausea. Bone loss and fractures require attention. Report jaundice, a severe rash or allergic symptoms promptly.
Overdose Protocol
For a suspected overdose, contact a poison-information service or urgent medical care and provide the product, amount, time and other substances taken. Collapse, seizures or breathing difficulty require emergency help. Do not induce vomiting or attempt an antidote at home. Clinical treatment depends on symptoms and the substances involved.
Scientific & Technical Data
Pharmacodynamics
Exemestane irreversibly inactivates aromatase. Its effect on oestrogen synthesis continues until the body produces new active enzyme.
Pharmacokinetics
Food increases exemestane exposure. The drug undergoes extensive metabolism, including CYP3A4-mediated pathways, and metabolites leave through urine and faeces. The mean terminal half-life is approximately 24 hours.
Storage and Handling
Exemestane tablets are generally kept at controlled room temperature. Keep tablets in their original, tightly closed container, protected from excess heat and moisture and out of the sight and reach of children. Follow the temperature limits and expiry date on the pack. Return expired or unwanted medicines through a pharmacy or medicine take-back programme; do not flush them.
Browse more